Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6513
    +0.0013 (+0.20%)
     
  • OIL

    82.90
    +0.09 (+0.11%)
     
  • GOLD

    2,330.50
    -7.90 (-0.34%)
     
  • Bitcoin AUD

    98,764.87
    -3,621.57 (-3.54%)
     
  • CMC Crypto 200

    1,389.91
    +7.34 (+0.53%)
     
  • AUD/EUR

    0.6077
    +0.0006 (+0.11%)
     
  • AUD/NZD

    1.0956
    +0.0014 (+0.13%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,218.38
    +17.11 (+0.10%)
     
  • NIKKEI 225

    37,615.02
    -845.06 (-2.20%)
     

Broker Revenue Forecasts For SciDev Limited (ASX:SDV) Are Surging Higher

Shareholders in SciDev Limited (ASX:SDV) may be thrilled to learn that the covering analyst has just delivered a major upgrade to their near-term forecasts. The revenue forecast for this year has experienced a facelift, with the analyst now much more optimistic on its sales pipeline.

Following the upgrade, the most recent consensus for SciDev from its solitary analyst is for revenues of AU$19m in 2020 which, if met, would be a huge 141% increase on its sales over the past 12 months. Prior to the latest estimates, the analyst was forecasting revenues of AU$13m in 2020. The consensus has definitely become more optimistic, showing a chunky increase in revenue forecasts.

View our latest analysis for SciDev

ASX:SDV Past and Future Earnings May 15th 2020
ASX:SDV Past and Future Earnings May 15th 2020

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analyst is definitely expecting SciDev's growth to accelerate, with the forecast 141% growth ranking favourably alongside historical growth of 29% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.9% next year. It seems obvious that, while the growth outlook is brighter than the recent past, the analyst also expect SciDev to grow faster than the wider industry.

The Bottom Line

The highlight for us was that the analyst increased their revenue forecasts for SciDev this year. The analyst also expects revenues to grow faster than the wider market. Seeing the dramatic upgrade to this year's forecasts, it might be time to take another look at SciDev.

ADVERTISEMENT

The covering analyst is definitely bullish on SciDev, but no company is perfect. Indeed, you should know that there are several potential concerns to be aware of, including dilutive stock issuance over the past year. For more information, you can click through to our platform to learn more about this and the 5 other concerns we've identified .

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are upgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.